General Information of Drug (ID: DMYPLCH)

Drug Name
Her-2/neu vaccine
Indication
Disease Entry ICD 11 Status REF
Ovarian cancer 2C73 Phase 1/2 [1]
Cross-matching ID
TTD ID
D0U3FP

References

1 ClinicalTrials.gov (NCT02336984) A Phase I/II Trial of HER-2/Neu Pulsed DC1 Vaccine Combined With Trastuzumab for Patients With DCIS. U.S. National Institutes of Health.